Description
| Product Name | CAT.No | Size |
| PT Low Sensitivity | COAG102A | 1 x 5ml |
| PT Low Sensitivity | COAG102B | 5 x 5ml |
| PT Low Sensitivity | COAG117A | 1 x 5ml |
| PT Low Sensitivity | COAG117B | 5 x 5ml |
Product Description
The Biorex Diagnostics PT Low Sensitivity reagent is an in vitro diagnostic assay specifically designed for performing the one-stage Prothrombin Time (PT) test and its related modified procedures. Engineered for precision, reliability, and ease of use, this reagent provides clinical laboratories, hospitals, and research facilities with a dependable solution for evaluating the extrinsic and common pathways of blood coagulation. Its consistent performance ensures accurate results, supporting both routine testing and specialised coagulation assessments.
Key Features
- Accurate Coagulation Measurement – precisely evaluates extrinsic and common coagulation pathways, ensuring dependable PT results for clinical decision-making.
- Supports Anticoagulant Monitoring – ideal for monitoring patients on oral anticoagulant therapy, such as warfarin, providing reliable data for dose adjustments and therapeutic management.
- Bleeding and Clotting Disorder Assessment – assists in diagnosing inherited or acquired haemostatic disorders, enabling timely intervention and patient care.
- User-Friendly Workflow – simple and straightforward procedure reduces laboratory handling errors, optimising routine PT testing for high-throughput environments.
- Strict Quality Control Standards – manufactured under rigorous clinical laboratory standards to ensure reproducibility, consistency, and reliability.
Benefits
The PT Low Sensitivity reagent enhances laboratory efficiency by delivering precise and reproducible coagulation measurements, supporting both routine testing and specialised diagnostic applications. Its use ensures safe and effective management of patients on anticoagulant therapy, helping clinicians to make informed decisions based on accurate clotting data. Furthermore, it aids in preoperative evaluation, cardiovascular risk assessment, and monitoring of coagulation-related conditions, including liver disease and certain malignancies.
By integrating the Biorex PT Low Sensitivity reagent into laboratory workflows, facilities can maintain high standards of testing quality, reduce variability, and provide clinicians with reliable results. Its combination of ease of use, clinical accuracy, and broad applicability makes it an essential tool for haemostasis testing, supporting improved patient outcomes, efficient laboratory operations, and long-term confidence in coagulation diagnostics.
Contact Us for more information.